BioSpace News Archive

Harpoon Therapeutics, Inc. announced today that it has appointed Natalie R. Sacks, M.D., as Chief Medical Officer.

DiaSorin Molecular LLC announced today that it has received CE marking for its new Simplexa™ VZV Direct assay. The new molecular diagnostic test enables the direct detection of varicella-zoster virus (VZV) DNA from cerebrospinal fluid (CSF).

Cognate BioServices today announced a letter of intent for a collaboration agreement with Terumo BCT, a leading technology provider in the cell therapy market.

Panel to Highlight Advanced Therapeutics for Oncology

GB Sciences explores the therapeutic potential of the chemical diversity within different varieties of the cannabis plant to make better medicine for patients worldwide.

On April 7, 2017, ThermoLife filed its request for the United States Patent Office to re-examine the patentability of Jack Owac’s “Super Creatine” patent: U.S. Patent No. 8,445,466. As a result of ThermoLife’s request, the USPTO has now rejected and cancelled ALL of Jack Owac’s patent claims to his so-called “Super Creatine.”

Program Candidates Address Growing Need for New Treatments Against Drug Resistant Gram-negative Bacteria, Including Carbapenem-resistant Enterobacteriaceae (CRE) and Pseudomonas

Iclaprim safety and efficacy in patients with wound infections in REVIVE Phase 3 trials

Pall Corporatio has progressed a strategic partnership with the University College London (UCL) Biochemical Engineering department with the creation of the UCL-Pall Biotech Centre of Excellence (CoE) for research and training.

BrainStorm Cell Therapeutics Inc. announced today that members of its executive team will present at the Northeast Amyotrophic Lateral Sclerosis (NEALS) Conference in Clearwater, Florida and the Cell & Gene Meeting on the Mesa 2018 Conference in La Jolla, California, both taking place today, October 3, 2018.